BARCLAYS PLC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in TRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,299,735

+$20,660,467 QoQ

Shares Held

1,142,077

+2031.3% QoQ

Ownership

0.802%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#39

of 216 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,036 across 455 Biotechnology names. TRVI ranks #14 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,299,735	1,142,077	+2031.3%	Shares	Defined	2026-08-14
2026-03-31	$639,268	53,585	-90.8%	Shares	Defined	2026-05-15
2025-12-31	$7,294,815	582,653	+168.6%	Shares	Sole	2026-02-13
2025-09-30	$1,984,497	216,885	+57.2%	Shares	Sole	2026-03-31
2025-03-31	$867,591	137,932	-11.7%	Shares	Sole	2026-03-17
2024-12-31	$643,820	156,267	+360.8%	Shares	Sole	2026-03-19
2024-06-30	$101,066	33,915	-3.6%	Shares	Sole	2026-03-23
2024-03-31	$121,422	35,195	-44.8%	Shares	Sole	2026-03-24
2023-12-31	$85,487	63,797	+380.2%	Shares	Sole	2026-03-24
2023-09-30	$28,961	13,285	+13185.0%	Shares	Sole	2026-03-26
2021-09-30	$140	100	0.0%	Shares	Sole	2021-11-09
2021-06-30	$225	100	+566.7%	Shares	Sole	2021-08-13
2020-06-30	$98	15	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.